首页 > 最新文献

Giornale italiano di cardiologia最新文献

英文 中文
[The Italian law 219/2017: informed consent and advance directives. When the patient-doctor communication time is law, but it is forgotten]. [意大利第 219/2017 号法律:知情同意和预先指示。当医患沟通时间成为法律,却被遗忘]。
IF 0.5 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-06-01 DOI: 10.1714/4269.42461
Massimo Romanò

The Italian law 217/2019 on "Informed consent and advance directives" is an important step forward in the redefinition of patient-doctor relationships. The law points out the principles of the decisional autonomy and freedom of the patient to choose the treatment options. However, it is underestimated and largely unapplied by the Italian cardiologists. The main elements of patient-doctor communication are present in the law. The most important is the time devoted to the patient-doctor relationship, necessary to ease the disease awareness. This time is clearly emphasized in the law, but the healthcare institutions did not arrange for the appropriate organizational procedures. Through the advance directives (ADs) the patients may express their own wishes about healthcare treatments, as well as their consent or refusal regarding the diagnostic or therapeutical doctors' suggestions, allowing their respect in case they become incompetent. This right is supported by the patients' designation of a healthcare proxy, who can interact for them with the healthcare team. However, after 6 years since the law enactment, only 0.4% of the Italian citizens signed ADs, due to insufficient information and organization by the healthcare authorities. In the Law, the advance care planning is closely related to ADs. In this process, the adults can understand and share their personal values, life goals and preferences, in order to define the potential future medical care and to discuss all the issues with family and physicians. These processes can be integrated in a broader shared decision-making, a strong tool of the patient-doctor alliance.

意大利关于 "知情同意和预先指示 "的第 217/2019 号法律是在重新定义医患关系方面迈出的重要一步。该法律指出了患者自主决定和自由选择治疗方案的原则。然而,意大利心脏病专家却低估了这一原则,而且在很大程度上没有加以应用。法律规定了医患沟通的主要内容。其中最重要的是专门用于医患关系的时间,这对于提高患者对疾病的认识十分必要。法律明确强调了这一时间,但医疗机构并未安排适当的组织程序。通过预嘱(ADs),病人可以表达自己对医疗保健治疗的意愿,以及对医生的诊断或治疗建议的同意或拒绝,从而在他们丧失能力时得到尊重。病人可以指定一名医疗保健代理来支持自己的这一权利,该代理可以代表他们与医疗保健团队进行交流。然而,在法律颁布 6 年后,只有 0.4% 的意大利公民签署了预先护理计划,原因是医疗机构提供的信息和组织不够充分。在该法律中,预先护理计划与预嘱密切相关。在这一过程中,成年人可以了解并分享他们的个人价值观、生活目标和偏好,以确定未来可能的医疗护理,并与家人和医生讨论所有问题。这些过程可以整合到更广泛的共同决策中,是医患联盟的有力工具。
{"title":"[The Italian law 219/2017: informed consent and advance directives. When the patient-doctor communication time is law, but it is forgotten].","authors":"Massimo Romanò","doi":"10.1714/4269.42461","DOIUrl":"10.1714/4269.42461","url":null,"abstract":"<p><p>The Italian law 217/2019 on \"Informed consent and advance directives\" is an important step forward in the redefinition of patient-doctor relationships. The law points out the principles of the decisional autonomy and freedom of the patient to choose the treatment options. However, it is underestimated and largely unapplied by the Italian cardiologists. The main elements of patient-doctor communication are present in the law. The most important is the time devoted to the patient-doctor relationship, necessary to ease the disease awareness. This time is clearly emphasized in the law, but the healthcare institutions did not arrange for the appropriate organizational procedures. Through the advance directives (ADs) the patients may express their own wishes about healthcare treatments, as well as their consent or refusal regarding the diagnostic or therapeutical doctors' suggestions, allowing their respect in case they become incompetent. This right is supported by the patients' designation of a healthcare proxy, who can interact for them with the healthcare team. However, after 6 years since the law enactment, only 0.4% of the Italian citizens signed ADs, due to insufficient information and organization by the healthcare authorities. In the Law, the advance care planning is closely related to ADs. In this process, the adults can understand and share their personal values, life goals and preferences, in order to define the potential future medical care and to discuss all the issues with family and physicians. These processes can be integrated in a broader shared decision-making, a strong tool of the patient-doctor alliance.</p>","PeriodicalId":12510,"journal":{"name":"Giornale italiano di cardiologia","volume":"25 6","pages":"383-389"},"PeriodicalIF":0.5,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141161237","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Advances in the treatment of complex atherosclerotic disease: cracking the calcium and beyond]. [治疗复杂性动脉粥样硬化疾病的进展:破解钙和超越]。
IF 0.7 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-06-01 DOI: 10.1714/4287.42686
Giulio Stefanini, Angelo Oliva
{"title":"[Advances in the treatment of complex atherosclerotic disease: cracking the calcium and beyond].","authors":"Giulio Stefanini, Angelo Oliva","doi":"10.1714/4287.42686","DOIUrl":"https://doi.org/10.1714/4287.42686","url":null,"abstract":"","PeriodicalId":12510,"journal":{"name":"Giornale italiano di cardiologia","volume":"25 6","pages":"3-4"},"PeriodicalIF":0.7,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141442447","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Stroke and stroke prevention in cardiac and thoracic aortic surgery]. [心脏和胸主动脉手术中的中风和中风预防]。
IF 0.5 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-06-01 DOI: 10.1714/4269.42466
Luca Di Marco, Silvia Snaidero, Alessandro Leone, Davide Pacini

Perioperative stroke and neurological injuries in general are complications that can occur during and after cardiac surgery, particularly in aortic surgery that involves the aortic arch. The overall incidence of early and delayed stroke is about 1% according to recent meta-analyses. This incidence depends on interindividual risk factor profile and type of surgery. In order to reduce cerebrovascular complications during cardiac surgery, a number of preventative measures can be taken, including the evaluation of atherosclerotic plaques, the site of cannulation and neuroprotection strategies. During aortic arch surgery, main strategies for cerebral protection are represented by deep hypothermic circulatory arrest, retrograde and antegrade cerebral perfusion.

围手术期中风和一般神经损伤是心脏手术期间和术后可能发生的并发症,尤其是涉及主动脉弓的主动脉手术。根据最近的荟萃分析,早期和延迟中风的总发生率约为 1%。这一发病率取决于个体间的风险因素和手术类型。为了减少心脏手术中的脑血管并发症,可以采取一些预防措施,包括评估动脉粥样硬化斑块、插管部位和神经保护策略。在主动脉弓手术中,脑保护的主要策略包括深低温循环停滞、逆行和逆行脑灌注。
{"title":"[Stroke and stroke prevention in cardiac and thoracic aortic surgery].","authors":"Luca Di Marco, Silvia Snaidero, Alessandro Leone, Davide Pacini","doi":"10.1714/4269.42466","DOIUrl":"10.1714/4269.42466","url":null,"abstract":"<p><p>Perioperative stroke and neurological injuries in general are complications that can occur during and after cardiac surgery, particularly in aortic surgery that involves the aortic arch. The overall incidence of early and delayed stroke is about 1% according to recent meta-analyses. This incidence depends on interindividual risk factor profile and type of surgery. In order to reduce cerebrovascular complications during cardiac surgery, a number of preventative measures can be taken, including the evaluation of atherosclerotic plaques, the site of cannulation and neuroprotection strategies. During aortic arch surgery, main strategies for cerebral protection are represented by deep hypothermic circulatory arrest, retrograde and antegrade cerebral perfusion.</p>","PeriodicalId":12510,"journal":{"name":"Giornale italiano di cardiologia","volume":"25 6","pages":"424-432"},"PeriodicalIF":0.5,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141161200","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Endovascular devices for severely calcified peripheral lesion preparation: state of the art]. [用于严重钙化外周病变准备工作的血管内设备:最新技术]。
IF 0.7 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-06-01 DOI: 10.1714/4287.42700
Attilio Leone, Nicola Verde, Luigi Salemme, Grigore Popusoi, Armando Pucciarelli, Michele Franzese, Giuseppe Di Gioia, Marco Ferrone, Francesco Spione, Sebastiano Verdoliva, Raffaele Moscato, Giovanni Esposito, Tullio Tesorio, Angelo Cioppa

Over the last few decades, endovascular revascularization techniques have revolutionized the treatment of peripheral artery disease, offering a less invasive alternative to surgery. However, the successful treatment of heavily calcified lesions is often compromised by various vascular complications, including recoils, dissections, and the need for target vessel reinterventions. This has prompted the development of several tools for lesion preparation, with the aim of achieving better procedural outcomes. This review aims to summarize the main characteristics and current evidence related to the available devices for preparing severely calcified peripheral lesions.

过去几十年来,血管内再通技术彻底改变了外周动脉疾病的治疗方法,为手术提供了一种创伤较小的替代方法。然而,重度钙化病变的成功治疗往往受到各种血管并发症的影响,包括反冲、剥离和靶血管再介入的需要。这促使人们开发了多种病变准备工具,以期获得更好的手术效果。本综述旨在总结用于准备严重钙化外周病变的现有设备的主要特点和现有证据。
{"title":"[Endovascular devices for severely calcified peripheral lesion preparation: state of the art].","authors":"Attilio Leone, Nicola Verde, Luigi Salemme, Grigore Popusoi, Armando Pucciarelli, Michele Franzese, Giuseppe Di Gioia, Marco Ferrone, Francesco Spione, Sebastiano Verdoliva, Raffaele Moscato, Giovanni Esposito, Tullio Tesorio, Angelo Cioppa","doi":"10.1714/4287.42700","DOIUrl":"10.1714/4287.42700","url":null,"abstract":"<p><p>Over the last few decades, endovascular revascularization techniques have revolutionized the treatment of peripheral artery disease, offering a less invasive alternative to surgery. However, the successful treatment of heavily calcified lesions is often compromised by various vascular complications, including recoils, dissections, and the need for target vessel reinterventions. This has prompted the development of several tools for lesion preparation, with the aim of achieving better procedural outcomes. This review aims to summarize the main characteristics and current evidence related to the available devices for preparing severely calcified peripheral lesions.</p>","PeriodicalId":12510,"journal":{"name":"Giornale italiano di cardiologia","volume":"25 6","pages":"16-22"},"PeriodicalIF":0.7,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141442449","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The technical-nursing contribution in the treatment of patients with complex coronary artery disease]. [护理技术在治疗复杂冠状动脉疾病患者中的贡献]。
IF 0.7 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-06-01 DOI: 10.1714/4287.42687
Francesco Germinal, Fabio Negrello, Matteo Migliorini, Nicola Leonardo Galizia, Matteo Longoni
{"title":"[The technical-nursing contribution in the treatment of patients with complex coronary artery disease].","authors":"Francesco Germinal, Fabio Negrello, Matteo Migliorini, Nicola Leonardo Galizia, Matteo Longoni","doi":"10.1714/4287.42687","DOIUrl":"10.1714/4287.42687","url":null,"abstract":"","PeriodicalId":12510,"journal":{"name":"Giornale italiano di cardiologia","volume":"25 6","pages":"5-7"},"PeriodicalIF":0.7,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141442424","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Optical coherence tomography-guided versus angiography-guided coronary angioplasty: results of the ILUMIEN IV randomized clinical trial]. [光学相干断层扫描引导的冠状动脉血管成形术与血管造影术引导的冠状动脉血管成形术:ILUMIEN IV 随机临床试验结果]。
IF 0.7 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-06-01 DOI: 10.1714/4287.42693
Evelina Toscano, Andrea Marrone, Giulia Botti, Arif Khokhar, Jonathan Curio, Federica Serino, Erik Rafflenbeul, Emanuele Barbato, Giulia Masiero
{"title":"[Optical coherence tomography-guided versus angiography-guided coronary angioplasty: results of the ILUMIEN IV randomized clinical trial].","authors":"Evelina Toscano, Andrea Marrone, Giulia Botti, Arif Khokhar, Jonathan Curio, Federica Serino, Erik Rafflenbeul, Emanuele Barbato, Giulia Masiero","doi":"10.1714/4287.42693","DOIUrl":"10.1714/4287.42693","url":null,"abstract":"","PeriodicalId":12510,"journal":{"name":"Giornale italiano di cardiologia","volume":"25 6","pages":"43-44"},"PeriodicalIF":0.7,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141442451","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Italian Society of Pediatric Cardiology (SICP) position paper on the prevention, diagnosis, treatment and follow-up of cardiotoxicity in pediatric patients with cancer]. [意大利儿科心脏病学会(SICP)关于儿科癌症患者心脏毒性的预防、诊断、治疗和随访的立场文件]。
IF 0.7 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-06-01 DOI: 10.1714/4269.42470
Elena Bennati, Biagio Castaldi, Maria Elena Derchi, Sabrina Spoto, Marcello Chinali, Nicoletta Bertorello, Calogero Comparato, Ugo Vairo, Gabriele Rinelli, Silvia Favilli

The survival of pediatric cancer patients has significantly increased thanks to the improvement of oncological treatments. Therefore, it is of utmost importance to manage short- and long-term cardiovascular complications. In pediatric cardio-oncology, there are no recognized guidelines as in adults. Several recommendations and many indications have been derived from the data obtained in the adult cancer population, resulting in greater discrepancies in the clinical management of patients. The aim of this position paper of the Italian Society of Pediatric Cardiology (SICP) is to collect the main evidence regarding the diagnosis, prevention, treatment and follow-up of cardiotoxicity in children, to provide useful indications for clinical practice, and to promote a network between pediatric centers.

由于肿瘤治疗方法的改进,儿童癌症患者的生存率大幅提高。因此,控制短期和长期心血管并发症至关重要。在儿科心血管肿瘤学方面,目前还没有像成人那样的公认指南。一些建议和许多适应症都是根据成人癌症患者的数据得出的,导致患者的临床管理存在较大差异。意大利儿科心脏病学会(SICP)的这份立场文件旨在收集有关儿童心脏毒性的诊断、预防、治疗和随访的主要证据,为临床实践提供有用的指征,并促进儿科中心之间的网络建设。
{"title":"[Italian Society of Pediatric Cardiology (SICP) position paper on the prevention, diagnosis, treatment and follow-up of cardiotoxicity in pediatric patients with cancer].","authors":"Elena Bennati, Biagio Castaldi, Maria Elena Derchi, Sabrina Spoto, Marcello Chinali, Nicoletta Bertorello, Calogero Comparato, Ugo Vairo, Gabriele Rinelli, Silvia Favilli","doi":"10.1714/4269.42470","DOIUrl":"10.1714/4269.42470","url":null,"abstract":"<p><p>The survival of pediatric cancer patients has significantly increased thanks to the improvement of oncological treatments. Therefore, it is of utmost importance to manage short- and long-term cardiovascular complications. In pediatric cardio-oncology, there are no recognized guidelines as in adults. Several recommendations and many indications have been derived from the data obtained in the adult cancer population, resulting in greater discrepancies in the clinical management of patients. The aim of this position paper of the Italian Society of Pediatric Cardiology (SICP) is to collect the main evidence regarding the diagnosis, prevention, treatment and follow-up of cardiotoxicity in children, to provide useful indications for clinical practice, and to promote a network between pediatric centers.</p>","PeriodicalId":12510,"journal":{"name":"Giornale italiano di cardiologia","volume":"25 6","pages":"453-463"},"PeriodicalIF":0.7,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141161171","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Venoarterial extracorporeal membrane oxygenation: from evidence to clinical practice]. [静脉体外膜肺氧合:从证据到临床实践]。
IF 0.5 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-06-01 DOI: 10.1714/4269.42465
Luigi Oltrona Visconti, Rita Camporotondo, Marco Ferlini, Simone Savastano, Ginevra Annoni, Alessandro Fasolino

Mortality for cardiogenic shock is still high despite optimal pharmacological therapy. Therefore, active mechanical circulatory support devices are increasingly used; venoarterial extracorporeal membrane oxygenation (VA-ECMO) enables full circulatory and respiratory support. However, recent data show that in patients with infarct-related shock unselected early use of VA-ECMO does not improve survival and is associated with major bleeding and peripheral ischemic complications. Nowadays, waiting for the results of definitive randomized controlled trials, the main indication for ECMO utilization is in selected patients with cardiac arrest, in those with shock for advanced heart failure refractory to conventional therapy, in those with fulminant myocarditis, in patients candidate for heart transplant or ventricular assistance, especially in presence of respiratory insufficiency and severe biventricular dysfunction. An important recommendation is its utilization in specialized, high-volume centers in the setting of hub and spoke hospitals.

尽管采用了最佳的药物治疗,心源性休克的死亡率仍然很高。因此,主动式机械循环支持装置的使用越来越多;静脉体外膜肺氧合(VA-ECMO)可实现全面的循环和呼吸支持。然而,最近的数据显示,在梗死相关休克患者中,未经选择的早期使用 VA-ECMO 并不能提高存活率,反而会导致大出血和外周缺血并发症。目前,在等待明确的随机对照试验结果的同时,ECMO 的主要适应症是经过选择的心脏骤停患者、常规治疗难治的晚期心衰休克患者、暴发性心肌炎患者、心脏移植或心室辅助的候选患者,尤其是存在呼吸功能不全和严重双心室功能障碍的患者。一项重要的建议是,在枢纽医院和辐条医院的背景下,在专业化、高容量中心使用该疗法。
{"title":"[Venoarterial extracorporeal membrane oxygenation: from evidence to clinical practice].","authors":"Luigi Oltrona Visconti, Rita Camporotondo, Marco Ferlini, Simone Savastano, Ginevra Annoni, Alessandro Fasolino","doi":"10.1714/4269.42465","DOIUrl":"10.1714/4269.42465","url":null,"abstract":"<p><p>Mortality for cardiogenic shock is still high despite optimal pharmacological therapy. Therefore, active mechanical circulatory support devices are increasingly used; venoarterial extracorporeal membrane oxygenation (VA-ECMO) enables full circulatory and respiratory support. However, recent data show that in patients with infarct-related shock unselected early use of VA-ECMO does not improve survival and is associated with major bleeding and peripheral ischemic complications. Nowadays, waiting for the results of definitive randomized controlled trials, the main indication for ECMO utilization is in selected patients with cardiac arrest, in those with shock for advanced heart failure refractory to conventional therapy, in those with fulminant myocarditis, in patients candidate for heart transplant or ventricular assistance, especially in presence of respiratory insufficiency and severe biventricular dysfunction. An important recommendation is its utilization in specialized, high-volume centers in the setting of hub and spoke hospitals.</p>","PeriodicalId":12510,"journal":{"name":"Giornale italiano di cardiologia","volume":"25 6","pages":"410-423"},"PeriodicalIF":0.5,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141161243","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Giant coronary aneurysm incidentally detected on transthoracic echocardiography in a patient with previous Bentall procedure]. [曾接受过 Bentall 手术的患者在经胸超声心动图检查中意外发现巨大冠状动脉瘤]。
IF 0.7 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-06-01 DOI: 10.1714/4269.42469
Francesco Briani, Alberto Dotto, Antonio Mugnolo

Coronary artery aneurysms represent a rare pathology (0.2-4.9% of patients undergoing coronary angiography) that may reach considerable size. The clinical presentation is various, manifesting as acute coronary syndrome or, conversely, remaining silent lifelong. We here report the case of an incidental finding by transthoracic echocardiography of a paracardiac mass of considerable size in a patient with vasculopathy that underwent a Bentall procedure for acute aortic dissection 18 years earlier. On thoracic computed tomography angiography, a 62 mm-sized giant aneurysm located in the proximal right coronary artery was evidenced. The optimal treatment of patients affected by coronary artery aneurysms remains debated; therefore, the therapeutic strategy should be individualized considering the etiology, clinical presentation, anatomical characteristics and concomitant presence of obstructive coronary artery disease.

冠状动脉瘤是一种罕见的病变(占接受冠状动脉造影术患者的 0.2-4.9%),可达到相当大的体积。其临床表现多种多样,可表现为急性冠状动脉综合征,也可反之,终身无症状。我们在此报告了一例经胸超声心动图偶然发现的心旁肿块病例,该患者曾在 18 年前因急性主动脉夹层接受过 Bentall 手术,并伴有血管病变。胸部计算机断层扫描血管造影显示,右冠状动脉近端有一个 62 毫米大小的巨大动脉瘤。对冠状动脉动脉瘤患者的最佳治疗方法仍存在争议;因此,治疗策略应根据病因、临床表现、解剖特征和同时存在的阻塞性冠状动脉疾病进行个体化。
{"title":"[Giant coronary aneurysm incidentally detected on transthoracic echocardiography in a patient with previous Bentall procedure].","authors":"Francesco Briani, Alberto Dotto, Antonio Mugnolo","doi":"10.1714/4269.42469","DOIUrl":"10.1714/4269.42469","url":null,"abstract":"<p><p>Coronary artery aneurysms represent a rare pathology (0.2-4.9% of patients undergoing coronary angiography) that may reach considerable size. The clinical presentation is various, manifesting as acute coronary syndrome or, conversely, remaining silent lifelong. We here report the case of an incidental finding by transthoracic echocardiography of a paracardiac mass of considerable size in a patient with vasculopathy that underwent a Bentall procedure for acute aortic dissection 18 years earlier. On thoracic computed tomography angiography, a 62 mm-sized giant aneurysm located in the proximal right coronary artery was evidenced. The optimal treatment of patients affected by coronary artery aneurysms remains debated; therefore, the therapeutic strategy should be individualized considering the etiology, clinical presentation, anatomical characteristics and concomitant presence of obstructive coronary artery disease.</p>","PeriodicalId":12510,"journal":{"name":"Giornale italiano di cardiologia","volume":"25 6","pages":"450-452"},"PeriodicalIF":0.7,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141161169","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Ticagrelor monotherapy in patients with acute coronary syndrome receiving new generation drug-eluting stents: results of the T-PASS randomized clinical trial]. [接受新一代药物洗脱支架治疗的急性冠状动脉综合征患者的替卡格雷单药治疗:T-PASS 随机临床试验结果]。
IF 0.7 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2024-06-01 DOI: 10.1714/4287.42692
Rossella Ruggiero, Alessandro Beneduce, Pierluigi Demola, Graziella Pompei, Alberto Barioli, Nicola Ryan, Emanuele Barbato, Marco Toselli
{"title":"[Ticagrelor monotherapy in patients with acute coronary syndrome receiving new generation drug-eluting stents: results of the T-PASS randomized clinical trial].","authors":"Rossella Ruggiero, Alessandro Beneduce, Pierluigi Demola, Graziella Pompei, Alberto Barioli, Nicola Ryan, Emanuele Barbato, Marco Toselli","doi":"10.1714/4287.42692","DOIUrl":"10.1714/4287.42692","url":null,"abstract":"","PeriodicalId":12510,"journal":{"name":"Giornale italiano di cardiologia","volume":"25 6","pages":"41-42"},"PeriodicalIF":0.7,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141442425","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Giornale italiano di cardiologia
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1